EPO Patents = 3

Trademarks = 29

Forward Citations = 4

Loading Chart...

2 inventors (with patents filed for the assignee):

Maher Albitar (6 out of 7 patents)

Hong J Zhang (1 out of 29 patents)

6 patents: Sort by Forward Citations

1. 10604801 - Deep sequecing of peripheral blood plasma DNA as a reliable test for confirming the diagnosis of myelodysplastic syndrome (2020-03-31),

2. 10550435 - Determining tumor load and biallelic mutation in patients with CALR mutation using peripheral blood plasma (2020-02-04),

3. 10329605 - Method to increase sensitivity of detection of low-occurrence mutations (2019-06-25),

4. 10253370 - High-sensitivity sequencing to detect BTK inhibitor resistance (2019-04-09),

5. 10227657 - Method for high sensitivity detection of MYD88 mutations (2019-03-12),

6. 9378407 - Automated fish reader using learning machines (2016-06-28),

NeoGenomics Laboratories is a leading oncology diagnostic testing company that provides comprehensive cancer testing and research services to hospitals, pathologists, oncologists, and biopharmaceutical companies. They offer a wide range of testing services, including cytogenetics, molecular testing, flow cytometry, and pathology services, to help guide personalized treatment decisions for patients with cancer.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

6 Patents

#9 in Fort Myers, FL

#1,397 in Florida

#43,755 in US

Fort Myers, FL, United States of America

Neogenomics Laboratories, Inc.

Forward Citations = 4

2 inventors:

Maher Albitar (6 out of 7 patents)

Hong J Zhang (1 out of 29 patents)

Please report any incorrect information to support@idiyas.com

3 patents (EPO):

Please report any incorrect information to support@idiyas.com